Skip to content

The effect of self-efficacy enhancement program on medication adherence

The effect of self-efficacy enhancement program on medication adherence among patients with acute coronary syndromes

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180623040204N1
Enrollment
90
Registered
2018-08-19
Start date
2018-08-12
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome. Chronic ischaemic heart disease, unspecified

Interventions

Intervention 1: Intervention group: The questionnaire will be completed as soon as the condition is fixed.Then, educational intervention will be provided to the patient in addition to routine therapeu

Sponsors

Shahroud University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: Being at the age of 20 or over Ability to speak and understand Persian language diagnosis of Acute coronary syndrome by a cardiologist.

Exclusion criteria

Exclusion criteria: Treatment-resistant ventricular arrhythmia and cardiojenic shock following illness having a history of cognitive impairment or known anxiety disorders based on patient's history and self-declaration and doctor's approval

Design outcomes

Primary

MeasureTime frame
Medication adherence score in self-efficacy for Appropriate Medication Use Scale (SEAMS). Timepoint: medication adherence measurement as soon as the patient's condition improves. It is done before the intervention and 40 days after the intervention. Method of measurement: Self-Efficacy for Appropriate Medication Use Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hossein Ebrahimi

Shahroud University of Medical Sciences

h_ebrahimi43@yahoo.com+98 23 3239 5054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026